http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Forma Therapeutics Presents Clinical Proof-of-Concept Data at the 62nd Annual ASH Meeting Supporting the Potential of its Novel Investigational PKR Activator, FT-4202, to Treat Sickle Cell Disease (SC
-
Forma Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
-
Forma Therapeutics Holdings (FMTX) Announces FT-4202 Receives Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease
-
Forma Therapeutics Announces FT-4202 Receives Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease
-
Forma Therapeutics Announces Four Oral and Poster Presentations on FT-4202 in Sickle Cell Disease at Upcoming 2020 ASH Virtual Annual Meeting
-
Forma Therapeutics to Participate in Upcoming Investor Conferences
-
Forma Therapeutics (FMTX) Announces Positive Top-line Olutasidenib Data From Planned Interim Analysis of Registrational Phase 2 Clinical Trial in Acute Myeloid Leukemia
-
Forma Therapeutics Announces Positive Top-line Olutasidenib Data From a Planned Interim Analysis of a Registrational Phase 2 Clinical Trial in Acute Myeloid Leukemia (AML)
-
Forma Therapeutics Appoints Two New Vice Presidents to Lead Key Organizational Functions
-
Forma Therapeutics Appoints Biopharma Veteran Thomas G. Wiggans to Board of Directors
-
Forma Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Forma Therapeutics Elects Distinguished Researcher and Physician Wayne A.I. Frederick, M.D., to Board of Directors
